Drug Shortage Report for IRBESARTAN/HCTZ
Report ID | 108350 |
Drug Identification Number | 02372908 |
Brand name | IRBESARTAN/HCTZ |
Common or Proper name | IRBESARTAN/HCT |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
Strength(s) | 25MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-01-08 |
Actual start date | 2020-12-10 |
Estimated end date | 2021-08-30 |
Actual end date | 2021-09-13 |
Shortage status | Resolved |
Updated date | 2021-09-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2021-09-14 | English | Compare |
v14 | 2021-09-13 | French | Compare |
v13 | 2021-09-13 | English | Compare |
v12 | 2021-07-05 | French | Compare |
v10 | 2021-07-05 | English | Compare |
v11 | 2021-07-05 | English | Compare |
v9 | 2021-04-19 | French | Compare |
v8 | 2021-04-19 | English | Compare |
v7 | 2020-12-11 | English | Compare |
v6 | 2020-12-10 | French | Compare |
v5 | 2020-12-10 | English | Compare |
v4 | 2020-08-04 | French | Compare |
v3 | 2020-08-04 | English | Compare |
v2 | 2020-03-10 | French | Compare |
v1 | 2020-03-10 | English | Compare |
Showing 1 to 15 of 15